Gary S. Guthart Sells 17,975 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) CEO Gary S. Guthart sold 17,975 shares of the business’s stock in a transaction dated Thursday, July 27th. The stock was sold at an average price of $937.27, for a total transaction of $16,847,428.25. Following the transaction, the chief executive officer now owns 101,798 shares in the company, valued at $95,412,211.46. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Shares of Intuitive Surgical, Inc. (ISRG) traded up 0.439% during trading on Friday, hitting $935.938. 177,122 shares of the company traded hands. Intuitive Surgical, Inc. has a one year low of $610.71 and a one year high of $974.66. The stock has a market cap of $34.77 billion, a price-to-earnings ratio of 44.829 and a beta of 0.39. The firm has a 50 day moving average price of $937.07 and a 200-day moving average price of $813.16.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, July 20th. The medical equipment provider reported $5.95 earnings per share for the quarter, topping the consensus estimate of $5.79 by $0.16. The business had revenue of $756.20 million for the quarter, compared to the consensus estimate of $724.51 million. Intuitive Surgical had a net margin of 28.44% and a return on equity of 15.99%. The firm’s quarterly revenue was up 12.8% compared to the same quarter last year. During the same period last year, the firm posted $5.62 earnings per share. Analysts predict that Intuitive Surgical, Inc. will post $23.86 EPS for the current year.

ISRG has been the topic of a number of recent analyst reports. Zacks Investment Research upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating and set a $911.00 price target on the stock in a research note on Monday, April 24th. Wedbush upped their target price on shares of Intuitive Surgical from $835.00 to $875.00 and gave the stock an “outperform” rating in a research report on Monday, April 24th. Leerink Swann restated an “outperform” rating on shares of Intuitive Surgical in a research report on Wednesday, July 5th. Barclays PLC upped their target price on shares of Intuitive Surgical from $870.00 to $1,000.00 and gave the stock an “overweight” rating in a research report on Friday, July 21st. They noted that the move was a valuation call. Finally, Morgan Stanley restated an “overweight” rating and set a $1,070.00 target price (up from $950.00) on shares of Intuitive Surgical in a research report on Tuesday. Six research analysts have rated the stock with a hold rating, thirteen have given a buy rating and one has assigned a strong buy rating to the stock. The company has a consensus rating of “Buy” and an average price target of $980.03.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in ISRG. Guardian Life Insurance Co. of America increased its position in Intuitive Surgical by 2.2% in the first quarter. Guardian Life Insurance Co. of America now owns 142 shares of the medical equipment provider’s stock valued at $109,000 after buying an additional 3 shares during the period. Greenleaf Trust increased its position in Intuitive Surgical by 0.8% in the first quarter. Greenleaf Trust now owns 477 shares of the medical equipment provider’s stock valued at $366,000 after buying an additional 4 shares during the period. Dynamic Advisors Solutions LLC increased its position in Intuitive Surgical by 0.6% in the first quarter. Dynamic Advisors Solutions LLC now owns 905 shares of the medical equipment provider’s stock valued at $694,000 after buying an additional 5 shares during the period. Bronfman E.L. Rothschild L.P. increased its position in Intuitive Surgical by 1.8% in the first quarter. Bronfman E.L. Rothschild L.P. now owns 280 shares of the medical equipment provider’s stock valued at $215,000 after buying an additional 5 shares during the period. Finally, Miles Capital Inc. increased its position in Intuitive Surgical by 1.3% in the first quarter. Miles Capital Inc. now owns 566 shares of the medical equipment provider’s stock valued at $434,000 after buying an additional 7 shares during the period. 97.56% of the stock is currently owned by institutional investors and hedge funds.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.